{"id":6021,"date":"2026-07-18T11:26:54","date_gmt":"2026-07-18T11:26:54","guid":{"rendered":"https:\/\/knight-pharma.com\/web\/?page_id=6021"},"modified":"2026-07-18T11:26:55","modified_gmt":"2026-07-18T11:26:55","slug":"kpi-amoxi-flox","status":"publish","type":"page","link":"https:\/\/knight-pharma.com\/web\/kpi-amoxi-flox\/","title":{"rendered":"KPI AMOXI FLOX"},"content":{"rendered":"
\n
\"\"<\/figure>\n<\/div>\n\n\n

COMPOSITION<\/mark><\/strong>
Each ml contains:
Amoxicillin ……………………………………………………….. 100 mg
Enrofloxacin ……………………………………………………… 50 mg
Solvents ad ……………………………………………………….. 1 ml<\/p>\n\n\n\n

INDICATIONS<\/mark><\/strong>
Indicated for the treatment of infections caused by organisms susceptible to amoxicillin and enrofloxacin, affecting the digestive, respiratory, and urogenital tracts, skin, and soft tissues.
Also indicated for the treatment of bacterial complications susceptible to this combination in diseases where such therapy is required.<\/p>\n\n\n\n

TARGET SPECIES<\/mark><\/strong>
Cattle, sheep, dogs, and cats.<\/p>\n\n\n\n

ADMINISTRATION AND DOSAGE<\/mark><\/strong>
Route of administration: Intramuscular or subcutaneous.<\/p>\n\n\n\n

All target species:
Administer 0.5\u20131 ml per 10 kg body weight per day<\/strong>.
The recommended duration of treatment is no longer than 5 days<\/strong>.
If no clinical improvement is observed within 48 hours<\/strong>, reassess the diagnosis.<\/p>\n\n\n\n

CONTRAINDICATIONS<\/mark><\/strong>
Do not administer to rabbits, guinea pigs, hamsters, or animals with a history of hypersensitivity to beta\u2011lactam antibiotics.<\/p>\n\n\n\n

SIDE EFFECTS<\/mark><\/strong>
Hypersensitivity reactions may occur, ranging from mild skin rashes to anaphylactic shock.
Local reactions at the injection site, gastrointestinal symptoms (particularly in herbivores), superinfections due to non\u2011susceptible organisms following prolonged use, and, in rare cases, blood dyscrasias and colitis may occur.<\/p>\n\n\n\n

INTERACTIONS<\/mark><\/strong>
Do not administer concurrently with bacteriostatic antibacterial agents, including tetracyclines, chloramphenicol, or sulfonamides.<\/p>\n\n\n\n

SPECIAL PRECAUTIONS<\/mark><\/strong>
Adjust the dose in animals with renal impairment.
Use dry, sterile syringes.
Gently massage the injection site after administration.
Do not administer intravenously.<\/p>\n\n\n\n

WARNING<\/mark><\/strong>
Shake well before use.<\/p>\n\n\n\n

WITHDRAWAL PERIOD<\/mark><\/strong>
Meat: 10 days
Milk: 10 days<\/p>\n\n\n\n

STORAGE<\/mark><\/strong>
Store between\u00a08\u202f\u00b0C and 15\u202f\u00b0C<\/strong>.
Protect from light.<\/p>\n\n\n\n

FOR VETERINARY USE ONLY<\/strong>
KEEP OUT OF REACH OF CHILDREN<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

COMPOSITIONEach ml contains:Amoxicillin ……………………………………………………….. 100 mgEnrofloxacin ……………………………………………………… 50 mgSolvents ad ……………………………………………………….. 1 ml INDICATIONSIndicated for the treatment of infections caused by organisms susceptible to amoxicillin and enrofloxacin, affecting the digestive, respiratory, and urogenital tracts, skin, and soft tissues.Also indicated for the treatment of bacterial complications susceptible to this combination in …<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"class_list":["post-6021","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages\/6021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/comments?post=6021"}],"version-history":[{"count":1,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages\/6021\/revisions"}],"predecessor-version":[{"id":6023,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages\/6021\/revisions\/6023"}],"wp:attachment":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/media?parent=6021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}